Effectiveness, Tolerability, Safety of Rasagiline in Early Parkinson's Disease Patients Without Levodopa
- Study Title
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
- Teva Identifier
- TVP-1012/232
- ClinicalTrials.gov Identifier
- NCT00203060
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline Mesylate | Drug: placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 35 Years and older
- Trial Duration
- 07/01/1997 - 07/01/2000
- Phase
- Phase 3